首页> 外文期刊>Therapeutic Drug Monitoring >Dosage Adjustment of Dabigatran Etexilate Based on Creatinine Clearance in Patients With Cardioembolic Stroke or Atrial Fibrillation
【24h】

Dosage Adjustment of Dabigatran Etexilate Based on Creatinine Clearance in Patients With Cardioembolic Stroke or Atrial Fibrillation

机译:基于肌酐清除率的达比加群酯的心律失常或心房颤动患者剂量调整

获取原文
获取原文并翻译 | 示例
       

摘要

Background: A recommendation for dosage adjustment of dabigatran etexilate, a prodrug of dabigatran, seems to be desirable based on creatinine clearance to avoid bleeding and stroke.
机译:背景:基于肌酐清除率的建议,达比加群酯的前药达比加群酯的剂量调整建议似乎是可取的,以避免出血和中风。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号